Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More

Immunotherapy is a major emerging treatment for breast cancer (BC). However, not all breast cancer patients derive benefit from immunotherapy. Predictive biomarkers of immunotherapy, such as tumor mutation burden and tumor-infiltrating lymphocytes, are promising to stratify the patients with BC and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Miao, Wenfang, He, Doudou, Wang, Siqi, Lou, Jianjuan, Jiang, Yanni, Wang, Shouju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207056/
https://www.ncbi.nlm.nih.gov/pubmed/34150736
http://dx.doi.org/10.3389/fbioe.2021.680315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207056/
https://www.ncbi.nlm.nih.gov/pubmed/34150736
http://dx.doi.org/10.3389/fbioe.2021.680315

Ejemplares similares